BRIDGER MANAGEMENT, LLC - Q1 2016 holdings

$1.45 Billion is the total value of BRIDGER MANAGEMENT, LLC's 40 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 31.6% .

 Value Shares↓ Weighting
MDCO BuyMEDICINES CO$98,528,000
-9.5%
3,101,298
+6.3%
6.81%
+89.2%
MGM  MGM RESORTS INTERNATIONAL$84,880,000
-5.6%
3,958,9700.0%5.87%
+97.3%
LH SellLABORATORY CORP AMER HLDGS$77,658,000
-22.0%
663,004
-17.7%
5.37%
+63.1%
POST SellPOST HLDGS INC$76,513,000
-10.9%
1,112,589
-20.1%
5.29%
+86.3%
AET SellAETNA INC NEW$62,926,000
+3.5%
560,087
-0.3%
4.35%
+116.5%
WMGI BuyWRIGHT MED GROUP N V$59,372,000
-8.1%
3,576,649
+33.8%
4.10%
+92.1%
TEVA SellTEVA PHARMACEUTICAL INDS LTDadr$59,320,000
-52.0%
1,108,574
-41.1%
4.10%
+0.4%
DXCM BuyDEXCOM INC$56,651,000
+147.9%
834,203
+199.0%
3.92%
+418.7%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$56,654,000
-1.1%
5,178,628
+4.7%
3.92%
+106.8%
KSU  KANSAS CITY SOUTHERN$56,586,000
+14.4%
662,2070.0%3.91%
+139.4%
CHTR  CHARTER COMMUNICATIONS INC Dcl a new$51,381,000
+10.6%
253,8220.0%3.55%
+131.2%
UNH SellUNITEDHEALTH GROUP INC$50,273,000
-29.8%
390,016
-36.0%
3.48%
+46.7%
STJ NewST JUDE MED INC$50,105,000911,008
+100.0%
3.46%
ALNY BuyALNYLAM PHARMACEUTICALS INC$50,041,000
-25.9%
797,212
+11.1%
3.46%
+54.9%
NKTR BuyNEKTAR THERAPEUTICS$48,359,000
+83.5%
3,517,011
+124.9%
3.34%
+283.7%
FB SellFACEBOOK INCcl a$47,990,000
-3.3%
420,598
-11.3%
3.32%
+102.1%
GRUB BuyGRUBHUB INC$41,602,000
+5.1%
1,655,468
+1.3%
2.88%
+119.8%
CNC SellCENTENE CORP DEL$37,593,000
-56.7%
610,566
-53.8%
2.60%
-9.5%
VRSN  VERISIGN INC$36,446,000
+1.3%
411,6370.0%2.52%
+111.9%
PACB BuyPACIFIC BIOSCIENCES CALIF IN$34,823,000
+22.9%
4,096,877
+89.8%
2.41%
+156.9%
CMG NewCHIPOTLE MEXICAN GRILL INC$31,849,00067,625
+100.0%
2.20%
WCG SellWELLCARE HEALTH PLANS INC$30,469,000
+5.1%
328,503
-11.4%
2.11%
+119.8%
TGTX BuyTG THERAPEUTICS INC$28,503,000
-22.1%
3,345,469
+9.0%
1.97%
+62.8%
LBRDA  LIBERTY BROADBAND CORP$25,351,000
+12.6%
435,8920.0%1.75%
+135.5%
THC NewTENET HEALTHCARE CORP$25,113,000868,044
+100.0%
1.74%
BYD BuyBOYD GAMING CORP$19,795,000
+85.1%
958,111
+78.0%
1.37%
+286.4%
MCRB BuySERES THERAPEUTICS INC$18,890,000
+41.2%
711,227
+86.5%
1.31%
+195.5%
TV  GRUPO TELEVISA SAspon adr rep ord$17,817,000
+0.9%
648,8250.0%1.23%
+110.8%
SGMS SellSCIENTIFIC GAMES CORPcl a$15,391,000
-43.2%
1,632,180
-46.0%
1.06%
+18.8%
TROV  TROVAGENE INC$15,301,000
-13.9%
3,290,5870.0%1.06%
+80.2%
ATRA BuyATARA BIOTHERAPEUTICS INC$14,072,000
-24.6%
739,444
+4.6%
0.97%
+57.7%
OPK NewOPKO HEALTH INC$13,863,0001,334,306
+100.0%
0.96%
LXRX SellLEXICON PHARMACEUTICALS INC$12,308,000
-36.0%
1,029,926
-28.7%
0.85%
+34.0%
SPNC NewSPECTRANETICS CORP$10,870,000748,642
+100.0%
0.75%
SPNE  SEASPINE HLDGS CORP$9,058,000
-14.8%
618,6840.0%0.63%
+78.3%
CHRS NewCOHERUS BIOSCIENCES INC$7,242,000341,121
+100.0%
0.50%
ADPTQ  ADEPTUS HEALTH INCcl a$6,916,000
+1.9%
124,5290.0%0.48%
+113.4%
WW  WEIGHT WATCHERS INTL INC NEWput$4,359,000
-36.3%
300,0000.0%0.30%
+33.2%
WW NewWEIGHT WATCHERS INTL INC NEW$1,799,000123,831
+100.0%
0.12%
CGIX  CANCER GENETICS INC$149,000
-13.9%
52,5080.0%0.01%
+66.7%
CMRX ExitCHIMERIX INC$0-841,898
-100.0%
-0.25%
EXAS ExitEXACT SCIENCES CORP$0-1,540,841
-100.0%
-0.47%
SHPG ExitSHIRE PLCsponsored adr$0-140,886
-100.0%
-0.96%
DYAX ExitDYAX CORP$0-982,413
-100.0%
-1.22%
SPY ExitSPDR S&P 500 ETF TRcall$0-7,286,800
-100.0%
-49.10%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1446817000.0 != 1446816000.0)

Export BRIDGER MANAGEMENT, LLC's holdings